APA (7th ed.) Citation

A, G., M, B., MJ, J., E, K., V, O., & M, Z. (2026). Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy: Analysis From the 2024-2025 Immunization Campaign in France. Obstetrics and gynecology, 147(1), 118. https://doi.org/10.1097/AOG.0000000000006121

Chicago Style (17th ed.) Citation

A, Gabet, Bertrand M, Jabagi MJ, Kolla E, Olié V, and Zureik M. "Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy: Analysis From the 2024-2025 Immunization Campaign in France." Obstetrics and Gynecology 147, no. 1 (2026): 118. https://doi.org/10.1097/AOG.0000000000006121.

MLA (9th ed.) Citation

A, Gabet, et al. "Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy: Analysis From the 2024-2025 Immunization Campaign in France." Obstetrics and Gynecology, vol. 147, no. 1, 2026, p. 118, https://doi.org/10.1097/AOG.0000000000006121.